Interleukin (IL)-13 is the predominant Th2 cytokine in localized cutaneous leishmaniasis lesions and renders specific CD4+ T cells unresponsive to IL-12.

Bourreau E, Prévot G, Pradinaud R, Launois P

Open source

DOI
10.1086/319249
Published
2001 Mar 15
Container
The Journal of infectious diseases
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1086/319249,
  title = {Interleukin (IL)-13 is the predominant Th2 cytokine in localized cutaneous leishmaniasis lesions and renders specific CD4+ T cells unresponsive to IL-12.},
  author = {Bourreau E and Prévot G and Pradinaud R and Launois P},
  year = {2001},
  journal = {The Journal of infectious diseases},
  doi = {10.1086/319249},
  url = {https://doi.org/10.1086/319249}
}

RIS

TY  - JOUR
TI  - Interleukin (IL)-13 is the predominant Th2 cytokine in localized cutaneous leishmaniasis lesions and renders specific CD4+ T cells unresponsive to IL-12.
AU  - Bourreau E
AU  - Prévot G
AU  - Pradinaud R
AU  - Launois P
PY  - 2001
JO  - The Journal of infectious diseases
DO  - 10.1086/319249
UR  - https://doi.org/10.1086/319249
ER  - 

APA

E, B., G, P., R, P., & P, L. (2001). Interleukin (IL)-13 is the predominant Th2 cytokine in localized cutaneous leishmaniasis lesions and renders specific CD4+ T cells unresponsive to IL-12.. The Journal of infectious diseases. https://doi.org/10.1086/319249

Source records